Thiotepa-busulfan-fludarabine compared to clofarabine-based conditioning for haploidentical transplant with posttransplant cyclophosphamide in patients with myeloid malignancies: a retrospective study from the SFGM-TC

Jullien M, Brissot E, Daguindau E, Loschi M, Bazarbachi A, Labussiere-Wallet H, Huynh A, Schmidt-Tanguy A, Charbonnier A, Turlure P, Beckerich F, Devillier R, Bay JO, Srour M, Ceballos P, Alani M, Souchet L, Marchand T, Rubio MT, Forcade E, Cornillon J, Chantepie S, Bulabois CE, Villate A, Garnier A, Peterlin P, Le Bourgeois A, Guillaume T, Chevallier P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC).Bone Marrow Transplant. 2025 Dec

Total Body Irradiation-Based Versus Chemotherapy-Alone Myleloblative Conditioning Regimen Before Hematopoietic Allogeneic Stem Cell Transplantation in Adults With Acute Lymphoblastic Leukemia: A Multi-Institutional Study From the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)

Belkacemi Y, Debbi K, To NH, Tour RP, Quero L, Balsat M, Martel-Lafay I, Beauvais D, Mirabel X, Forcade E, Batard S, Devillier R, Gonzague-Casabianca L, Chevallier P, Guimas V, Brissot E, Maertens J, Poiré X, Ceballos P, Llorente CC, Bilger K, Bulabois CE, Cherif AM, Coraggio G, Quoc SN, Robin M, Loganadane G.Int J Radiat Oncol Biol Phys. 2025 Oct 22

Haploidentical hematopoietic stem cell transplantation in the treatment of pediatric hematological malignancies (SFGM-TC)

Sirvent A, Angoso M, Calvo C, Berceanu A, El Quessar A, Fabaron C, Diana JS, Ait D, Fadwa Q, El Kababri M, Paillard C.Bull Cancer. 2025 Sep 24

Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in Europe

Pennings ER, Spanjaart AM, Thielen FW, Oerlemans S, Fleischer A, Sanges C, Gomes Da Silva M, Cabrerizo Y, Lecot P, Roux-Opstaele L, Dreuillet C, Gonzalez-Marcano E, Millán O, Jaeger U, Delgado J, Luu M, Huber B, Lorrain M, Galhardas Pina M, Kremer A, Bolanos N, Clavreul S, Nier S, Liu RDK, Lissenberg-Witte BI, Anguille S, Robin M, Morris EC, Sureda A, Préau M, Pannard M, De Bock GH, Wagers SS, Trebeden-Negre H, Maucort-Boulch D, Hudecek M, Uyl-de Groot CA, Kersten MJ.Blood Adv. 2025 Sep 24

Choice of bridging therapy prior to reinjection of autologous CAR-T cells in patients aged 0-25 years treated for B-ALL (SFGM-TC)

Pochon C, Rabian F, Brissot E, Chauvet P, Olivier L, Magro L, Dourthe ME.Bull Cancer. 2025 Sep 19

Acute graft-versus-host disease therapy: Which third line treatment after steroids and ruxolitinib? (SFGM-TC)

Coman T, Andreozzi F, Bay JO, Cornillon J, Guillaume T, Hamzy F, Souchet L, Turlure P, Marçais A, Dachy F, Beguin Y, Bulabois CE, Daghri S, Huynh A, Magro L, Chalandon Y.Bull Cancer. 2025 Sep 5

Anticipation of pharmacotherapeutic problems prior to allo stem cell transplantation in patients with co-morbidities (SFGM-TC)

Simon N, Bonnin A, Jouvance A, Masouridi-Levrat S, Forcade E, Roch-Torreilles I, Coiteux V, Magro L, Le Bourgeois A.Bull Cancer. 2025 Aug 11

Oral decitabine and cedazuridine maintenance after haematopoietic stem-cell transplantation in very high-risk acute myeloid leukaemia or myelodysplastic syndrome (GFM-DACORAL-DLI): a multicentre, single-arm, phase 2 trial

Robin M, D’Aveni M, Stamatoullas A, Raffoux E, Chevallier P, Garnier A, Mediavilla C, Carre M, Himberlin C, Sébert M, Ravinet A, Desseaux K, Labussière H, Alani M, Rubio MT, Huynh A, Adès L, de Latour RP, Paul F, Chermat F, Petit R, Mokeddem C, Charbonnier A, Thépot S, Chevret S, Fenaux P; Société Francophone de Greffe de Moelle et de Thérapie Cellulaire (SFGM-TC) and the Groupe Francophone des Myélodysplasies (GFM).Lancet Haematol. 2025 Aug 7

Management for HSC collected from related donor living in Maghreb for a patient transplanted in a France (SFGM-TC)

Giraud C, Ader V, Amokrane K, Benakli M, Bezsera SM, Hascoet Leberre I, Le Bars L, Letoffet J, Piot T, Poullain M, Talouarn M, Wallart A, Magro L, Yafour N.Bull Cancer. 2025 Jul 23

End of COBE2991: What alternatives are available for the preparation of each type of cell therapy products? (SFGM-TC)

Nasone J, Goncalves CA, Ballot C, Birba U, Bouabdelli M, Capin L, Clerc A, Vérité MAG, Hajjout K, Haquette A, Lafarge X, Magrin E, Pierre F, Schwartz E, Calmels B, Rouard H, Magro L, Mialou V.Bull Cancer. 2025 Jul 16

Allogeneic Hematopoietic Stem Cell Transplantation forElderly Acute Lymphoblastic Leukemia Patients: A RegistryStudy From the Société Francophone de Greffe de Moelle etThérapie Cellulaire (SFGM-TC)

Chalandon Y, Devillier R, Boumendil A, Nguyen S, Bulabois CE, Ceballos P, Brissot E, Rubio MT, Labussière-Wallet H, Maertens J, Chevallier P, Maillard N, Poiré X, Castilla-Llorente C, Beguin Y, Cornillon J, Maury S, Marchand T, Daguindau E, Bay JO, Turlure P, Joris M, Menard AL, Bilger K, Guillerm G, François S, Bazarbachi A, Chantepie S, Lewalle P, Marçais A, Loschi M, Benakli M, Chauvet P, Forcade E, Huynh A, Robin M, Masouridi-Levrat S. American Journal of Hematology. 2025 July

Selection of blood products to reduce immunization before HLA-mismatched allogeneic transplantation (SFGM-TC)

Crocchiolo R, Avias M, Baud C, Croisille L, Francois M, Guillaume N, Harfouch E, Pajot T, Pedini P, Wojciechowski E, Magro L, Dubois V.Bull Cancer. 2025 Jun 28

Real-world outcomes of haplo-HSCT with post-transplant cyclophosphamide in pediatric hematologic malignancies: a study on behalf of SFGM-TC and SFCE

Calvo C, Hautefeuille C, Vasseur L, Chevillon F, Nazon C, Bruno B, Ansari M, Sterin A, Sirvent A, Grain A, Angoso M, Gandemer V, Schneider P, Halfon-Domenech C, Rohrlich PS, Pochon C, Paillard C, Nguyen Quoc S, Raus N, Strullu M, Méchinaud F, Dhedin N, Dalle JH.Bone Marrow Transplant. 2025 Apr 13

CNS manifestations in acute and chronic graft-versus-host disease

Lambert N, Forte F, El Moussaoui M, Monseur J, Raus N, Polushin A, Michonneau D, Shultz C, Hogan WJ, Balaguer-Roselló A, Gil-Perotín S, Brijs J, Chauvet P, Gavriilaki M, Carre M, Dulamea AO, Chalandon Y, Salmenniemi U, Duminuco A, Ram R, García-Cadenas I, Porto G, Nguyen S, Smallbone P, González-Vicent M, Santoro JD, Willems E, Baron F, Servais S, Beguin Y, Maquet P; CNS-GvHD Study Group.Brain. 2025 Apr 3

Efficacy and safety of belumosudil for treatment of cGVHD: multicenter retrospective analysis of the French cohort of the compassionate use program, on behalf of the SFGM-TC

Michonneau D, Malard F, Le Grand S, Magro L, D’Aveni M, Tudesq JJ, Villate A, Meunier M, Maillard N, Castilla-Llorente C, Marçais A, Cabrera Q, Huynh A, Menard AL, Forcade E, Labussière-Wallet H, Raus N, Loschi M.Bone Marrow Transplant. 2025 Apr 1

Identification of the conditions and minimum requirements necessary for the release of autologous fresh CAR T-cell products under hospital exemption: a position paper from the WP-bioproduction of the UNITC consortium

Boyer O, Bensoussan D, Bönig H, Chabannon C, Clémenceau B, Cuffel A, Dachy G, de Vos J, Derenne S, Diana JS, Dougé A, Deramoudt L, Ferrand C, Forcade E, Galaine J, Galy A, Giverne C, Martinet J, Marton C, Larghero J, Reppel L, Viel S, Yakoub-Agha I, Deschamps M.Bone Marrow Transplant. 2025 Jan 25

Setting up haploidentical hematopoietic cell transplantation in low- and middle-income countries: The Recommendations of the Francophone Society of Bone Marrow and Cellular Therapy (SFGM-TC)

Hamzy F, Chevallier P, Bruno B, Coiteux V, El Kababri M, Ibrahim A, Oudrhiri A, Yakoub-Agha I, Bekadja MA.Bull Cancer. 2025 Jan;11

Medical simulation training for bone marrow harvesting from a healthy donor for an allogeneic hematopoietic cell transplant (SFGM-TC)

Alsuliman T, Magro L, Titecat M, Robin M, Kanouni T, Forcade E, Jubert C, Yakoub-Agha I, Faucher C.Bull Cancer. 2024 Dec 12

Sexual and emotional life among patients with hematological malignancy-Special concerns in low- and middle- income countries (LMICs)

Alsuliman T, Musiu P, AlAsadi L, Aljarad Z, Marjanovic Z, Beitinjaneh A, Garidi R.Curr Res Transl Med. 2024 Nov 26

Incidence and risk factors of graft failure in allogeneic hematopoietic stem cell transplantation for mucopolysaccharidosis in a nationwide pediatric cohort. A study on behalf of the SFGM-TC

Danhardt L, Wiedemann A, Michel G, Dalle JH, Rialland F, Renard C, Jubert C, Maertens J, Sirvent A, Buchbinder N, Devalck C, Brichard B, Paillard C, Nguyen S, Paci A, Combarel D, Castelle M, Pagliuca S, Pochon C.EJHaem. 2024 Nov 26

Publications